ArticleParasitology2025

Preclinical evaluation of immunogenicity and protective efficacy of a recombinant chimeric protein vaccine against visceral leishmaniasis.

Daniela P Lage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.